{
    "clinical_study": {
        "@rank": "68692", 
        "arm_group": [
            {
                "arm_group_label": "10-core prostate biopsy protocol group", 
                "arm_group_type": "Active Comparator", 
                "description": "Ultrasound guided prostate biopsy with extraction of 10 cores"
            }, 
            {
                "arm_group_label": "Vienna nomogram prostate biopsy protocol group", 
                "arm_group_type": "Active Comparator", 
                "description": "Ultrasound guided prostate biopsy performed according to the Vienna nomogram"
            }
        ], 
        "brief_summary": {
            "textblock": "In this study, the investigators aim to determine if the Vienna nomogram increases the\n      detection rate of TRUS-guided prostate biopsies by conducting a prospective randomized study\n      comparing the Vienna nomogram with a 10-core biopsy protocol."
        }, 
        "brief_title": "A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10-core Biopsy Scheme", 
        "completion_date": {
            "#text": "July 2010", 
            "@type": "Actual"
        }, 
        "condition": "Prostate Cancer", 
        "condition_browse": {
            "mesh_term": "Prostatic Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "Trans rectal ultrasound (TRUS) guided prostate biopsy remains the standard for prostate\n      cancer diagnosis. However, the standard protocols miss 15 to 30% of cancers, leading to a\n      variable number of repeat biopsies.\n\n      In 2005 the Vienna nomogram was introduced, defining the number of cores to be obtained in a\n      prostate biopsy in relation to age and prostate volume in patients with a serum PSA level of\n      2-10 ng/mL.\n\n      The objective of the study is to determine if the Vienna nomogram increases the detection\n      rate of trans rectal ultrasound guided prostate biopsies, compared to a 10-core biopsy.\n\n      This prospective randomized study enrolled men eligible for a prostate biopsy were\n      randomized to a Vienna nomogram protocol or a 10-core protocol. They were further stratified\n      according to age (\u226465; >65 and \u226470; >70 years) and prostate volume (\u226430; >30 and \u226450; >50\n      and \u226470; >70 cc).\n\n      A subgroup analysis for patients with serum PSA values between 2 and 10 ng/mL was performed."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  PSA elevation\n\n          -  Abnormal digital rectal examination\n\n          -  Abnormal findings on prostate imaging\n\n        Exclusion Criteria:\n\n          -  Active urinary tract infection\n\n          -  Documented previous pathological prostatitis\n\n          -  History of urinary retention\n\n          -  Recent lower urinary tract surgery"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "463", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01752140", 
            "org_study_id": "BPTRVienna"
        }, 
        "intervention": [
            {
                "arm_group_label": "10-core prostate biopsy protocol group", 
                "description": "Local vascular bundle anesthesia with 2% lidocaine was performed using a 22G Chiba needle. Ultrasound guided prostate biopsy using a standard biopsy device to obtain 10 biopsy cores.", 
                "intervention_name": "10-core prostate biopsy protocol", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Vienna nomogram prostate biopsy protocol group", 
                "description": "Local vascular bundle anesthesia with 2% lidocaine was performed using a 22G Chiba needle. Ultrasound guided prostate biopsy using a standard biopsy device to obtain a number of cores as defined by the Vienna nomogram.", 
                "intervention_name": "Vienna nomogram prostate biopsy protocol", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Prostate cancer", 
            "Prostate biopsy", 
            "Vienna nomogram"
        ], 
        "lastchanged_date": "December 15, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Lisboa", 
                    "country": "Portugal", 
                    "state": "Lisbon", 
                    "zip": "1649-035"
                }, 
                "name": "Urology Department - Hospital de Santa Maria"
            }
        }, 
        "location_countries": {
            "country": "Portugal"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10-core Biopsy Scheme", 
        "overall_official": {
            "affiliation": "Hospital de Santa Maria", 
            "last_name": "Tito P Leit\u00e3o, Dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Portugal: Comiss\u00e3o de \u00c9tica para a Sa\u00fade do CHLN/FML", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Prostate cancer detection rate", 
            "safety_issue": "No", 
            "time_frame": "Up to four weeks after intervention"
        }, 
        "reference": [
            {
                "PMID": "7502425", 
                "citation": "Uzzo RG, Wei JT, Waldbaum RS, Perlmutter AP, Byrne JC, Vaughan ED Jr. The influence of prostate size on cancer detection. Urology. 1995 Dec;46(6):831-6."
            }, 
            {
                "PMID": "17342490", 
                "citation": "Djavan B, Margreiter M. Biopsy standards for detection of prostate cancer. World J Urol. 2007 Mar;25(1):11-7. Epub 2007 Mar 7. Review."
            }, 
            {
                "PMID": "21087452", 
                "citation": "Lecuona A, Heyns CF. A prospective, randomized trial comparing the Vienna nomogram to an eight-core prostate biopsy protocol. BJU Int. 2011 Jul;108(2):204-8. doi: 10.1111/j.1464-410X.2010.09887.x. Epub 2010 Nov 19."
            }, 
            {
                "PMID": "16145388", 
                "citation": "Remzi M, Fong YK, Dobrovits M, Anagnostou T, Seitz C, Waldert M, Harik M, Marihart S, Marberger M, Djavan B. The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J Urol. 2005 Oct;174(4 Pt 1):1256-60; discussion 1260-1; author reply 1261."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01752140"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hospital de Santa Maria, Portugal", 
            "investigator_full_name": "Tito Palmela Leit\u00e3o", 
            "investigator_title": "Dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Prostate cancer detection rate in prostate volume and age subclasses", 
                "safety_issue": "No", 
                "time_frame": "Up to four weeks after intervention"
            }, 
            {
                "measure": "Gleason score concordance between biopsy and prostatectomy specimens", 
                "safety_issue": "No", 
                "time_frame": "Up to four weeks after prostatectomy"
            }
        ], 
        "source": "Hospital de Santa Maria, Portugal", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospital de Santa Maria, Portugal", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2009", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}